TAG:
smear test
Digene, Ivax Diagnostics, Myriad Genetics, Bioscientia, LabOne, Aetna
ROTARY CLUBS LAUNCH MEXICO-BASED CERVICAL SCREENING EFFORT IN MEXICO, Rotary International will attack the problem of cervical cancer among Mexican women by supporting a screening program that utilizes human papillomavirus (HPV) testing. Called “Test for Life,†the prog…
DNA Diagnostics Market, Kaiser Permanente, TriPath Imaging, LifeScan
By Robert Michel | From the Volume VIII No. 1 – January 15, 2001 Issue
DNA DIAGNOSTICS MARKET GROWTH TO BE DOMINATED BY PCR TECHNOLOGY FOR THE YEAR 2000, total DNA diagnostic technology sales were estimated to be $517 million. By 2005, this number should increase to $771 million, a growth rate of 8.4% per year. This is the conclusion of Laura Roth, author of â…
Year’s Ten Biggest Stories Reveal Modest Changes
By Robert Michel | From the Volume VII No. 17 – December 4, 2000 Issue
CEO SUMMARY: In many ways, 2000 was a relatively quiet year for laboratory organizations. This list of the ten biggest stories in the lab industry for 2000 demonstrates that the most innovative laboratory organizations in the United States are “raising the bar†for service and quality…
Accurate Costing of New Pap Technology Proves Interesting
By Robert Michel | From the Volume VII No. 13 – September 11, 2000 Issue
CEO SUMMARY: Various new technologies intended to supplant conventional Pap smear screening must deliver improved clinical performance in a cost-effective manner. Joseph Plandowski, our guest writer,concludes his three-part series on new Pap smear technologies by evaluating actual lab cos…
Market Hesitates to Embrace Automated Screening Products
By Robert Michel | From the Volume VII No. 12 – August 21, 2000 Issue
CEO SUMMARY: Technology to enhance and improve conventional Pap smear screening was introduced into the clinical marketplace almost five years ago. But the clinical laboratory industry has yet to embrace these various technologies in any meaningful way. Like the introduction of liquid pre…
Qualigen’s POL PSA Test Cleared for Sale by FDA
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Qualigen, Inc. gained FDA approval to sell its FastPackâ„¢ System for PSA testing in the United States. Qualigen is one more example of a technology company that expects to shift diagnostic testing out of core laboratories and closer to the patient. Initially Qualigen will se…
Questions Remain About Performance Of Liquid-Prep Paps
By Robert Michel | From the Volume VII No. 9 – June 19, 2000 Issue
CEO SUMMARY: During the past five years, several companies entered the lab marketplace with claims that their new Pap test technologies are improvements over conventional Pap smear methods. Armed with investment capital from Wall Street, these companies launched aggressive sales and marke…
Pap Technology Wars Expected to Intensify
By Robert Michel | From the Volume VII No. 5 – March 27, 2000 Issue
CEO SUMMARY: With patience and persistence, Digene, Inc. is developing the effectiveness of its DNA-based HPV assay. Publication of recently-completed clinical trials provides evidence that Digene’s Hybrid Capture II ® HPV test, with further improvement, might become a relevant tool in…
Digene Corp’s HPV Test Attracts More Attention
By Robert Michel | From the Volume VII No. 2 – January 24, 2000 Issue
CEO SUMMARY: Evidence accumulates that HPV testing may be an effective way to identify women at risk for cervical cancer. Both Laboratory Corporation of America and Quest Diagnostics Incorporated recently added Digene’s Hybrid Capture® II HPV test to their menu. The intent is to offer …
Pap Smear Marketplace Shifting into High Gear
By Robert Michel | From the Volume VI No. 14 – October 11, 1999 Issue
CEO SUMMARY: It took just four years to shake out the weakest competitors in the emerging field of automated cytology. Now only TriPath Imaging, Inc. and Cytyc Corporation remain in competition. Indications are that this will be a nasty battle. Pathologists and lab executives contemplatin…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized